APO M250 (Mycophenolate Mofetil 250 mg)
Pill with imprint APO M250 is Blue & Pink, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Apotex Corp..
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO M250
- APO M250
- 250 mg
- Blue & Pink
- 19.00 mm
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
croscarmellose sodium, magnesium stearate, gelatin, sodium lauryl sulfate, ferric oxide red, titanium dioxide, indigotindisulfonate sodium, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, ferrosoferric oxide, potassium hydroxide, water
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|68084-0587||Amerisource Health Services|
Related Images for "APO M250"
More about mycophenolate mofetil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 50 Reviews
- Drug class: selective immunosuppressants
- FDA Alerts (3)
- Mycophenolate mofetil oral/injection
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
- ... +2 more
Other brands: CellCept
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.